
USA - NASDAQ:MDCO -
The current stock price of MDCO is 84.9 null. In the past month the price increased by 0.99%. In the past year, price increased by 356.21%.
The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.
MEDICINES CO
8 SYLVAN WAY
PARSIPPANY NJ 07054
CEO: Mark Timney
Phone: 973-290-6000
The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.
The current stock price of MDCO is 84.9 null. The price decreased by -0.07% in the last trading session.
MDCO does not pay a dividend.
MDCO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDCO.
ChartMill assigns a technical rating of 10 / 10 to MDCO. When comparing the yearly performance of all stocks, MDCO is one of the better performing stocks in the market, outperforming 99.5% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to MDCO. MDCO has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months MDCO reported a non-GAAP Earnings per Share(EPS) of -2.98. The EPS increased by 32.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.35% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |